v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2023   114,659      
Beginning balance at Mar. 31, 2023 $ 99,906 $ 115 $ 905,635 $ (12,927) $ (792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans, less withholding (in shares)   7,613      
Issuance of common stock under stock plans 0 $ 7 (7)    
ESPP issuance (in shares)   1,884      
ESPP share issuance 4,884 $ 2 4,882    
Stock-based compensation expense 63,386   63,386    
Issuance of common stock under stock plans related to acquisitions (in shares)   1,038      
Issuance of common stock related to acquisitions 0 $ 1 (1)    
Unrealized gain (loss) on investments in securities 280     280  
Foreign currency translation adjustment 1,094     1,094  
Net loss (67,592)       (67,592)
Ending balance (in shares) at Mar. 31, 2024   125,194      
Ending balance at Mar. 31, 2024 101,958 $ 125 973,895 (11,553) (860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans, less withholding (in shares)   6,445      
Issuance of common stock under stock plans 0 $ 7 (7)    
ESPP issuance (in shares)   2,387      
ESPP share issuance 3,692 $ 2 3,690    
Stock-based compensation expense 41,200   41,200    
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)   (175)      
Common shares withheld for settlement of taxes in connection with equity-based compensation (420)   (420)    
Issuance of common stock under stock plans related to acquisitions (in shares)   504      
Issuance of common stock related to acquisitions 544   544    
Unrealized gain (loss) on investments in securities (5)     (5)  
Foreign currency translation adjustment 2,447     2,447  
Net loss $ (27,212)       (27,212)
Ending balance (in shares) at Mar. 31, 2025 134,355 134,355      
Ending balance at Mar. 31, 2025 $ 122,204 $ 134 1,018,902 (9,111) (887,721)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans, less withholding (in shares)   6,668      
Issuance of common stock under stock plans 0 $ 6 (6)    
ESPP issuance (in shares)   1,851      
ESPP share issuance 2,829 $ 2 2,827    
Stock-based compensation expense 20,220   20,220    
Repurchase of common stock (in shares)   (1,000)      
Repurchase of common stock (1,848) $ (1) (1,847)    
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)   (710)      
Common shares withheld for settlement of taxes in connection with equity-based compensation (1,351)   (1,351)    
Unrealized gain (loss) on investments in securities 0        
Foreign currency translation adjustment 2,907     2,907  
Net loss $ 1,648       1,648
Ending balance (in shares) at Mar. 31, 2026 141,164 141,164      
Ending balance at Mar. 31, 2026 $ 146,609 $ 141 $ 1,038,745 $ (6,204) $ (886,073)